168 related articles for article (PubMed ID: 12935943)
1. Targeted toxins in pain.
Wiley RG; Lappi DA
Adv Drug Deliv Rev; 2003 Aug; 55(8):1043-54. PubMed ID: 12935943
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxins and neuropeptide-toxin conjugates experimental applications.
Lappi DA; Wiley RG
Mini Rev Med Chem; 2004 Jun; 4(5):585-95. PubMed ID: 15180512
[TBL] [Abstract][Full Text] [Related]
3. Targeted toxins.
Wiley RG; Lappi DA
Curr Protoc Neurosci; 2001 May; Chapter 1():Unit1.7. PubMed ID: 18428453
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide-toxin conjugates in pain research and treatment.
Wiley RG
Reg Anesth Pain Med; 2000; 25(5):546-8. PubMed ID: 11009244
[No Abstract] [Full Text] [Related]
5. Neuronal lesioning with axonally transported toxins.
Wiley RG; Kline IV RH
J Neurosci Methods; 2000 Nov; 103(1):73-82. PubMed ID: 11074097
[TBL] [Abstract][Full Text] [Related]
6. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
Lorberboum-Galski H
Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunotoxins bearing a single saporin molecule with multiple toxin conjugates.
Flavell DJ; Flavell SU
Methods Mol Biol; 2001; 166():87-100. PubMed ID: 11217378
[No Abstract] [Full Text] [Related]
8. Immunotoxins for targeted cancer therapy.
Kreitman RJ
AAPS J; 2006 Aug; 8(3):E532-51. PubMed ID: 17025272
[TBL] [Abstract][Full Text] [Related]
9. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.
Stratford EW; Bostad M; Castro R; Skarpen E; Berg K; Høgset A; Myklebost O; Selbo PK
Biochim Biophys Acta; 2013 Aug; 1830(8):4235-43. PubMed ID: 23643966
[TBL] [Abstract][Full Text] [Related]
10. Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.
Giansanti F; Flavell DJ; Angelucci F; Fabbrini MS; Ippoliti R
Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29438358
[TBL] [Abstract][Full Text] [Related]
11. Immunotoxins and other conjugates: preparation and general characteristics.
Fracasso G; Bellisola G; Castelletti D; Tridente G; Colombatti M
Mini Rev Med Chem; 2004 Jun; 4(5):545-62. PubMed ID: 15180510
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of anticancer immunotoxins.
Choudhary S; Mathew M; Verma RS
Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052
[TBL] [Abstract][Full Text] [Related]
13. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin.
Weyergang A; Selbo PK; Berg K
J Control Release; 2006 Mar; 111(1-2):165-73. PubMed ID: 16466823
[TBL] [Abstract][Full Text] [Related]
14. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning.
Wiley RG
Trends Neurosci; 1992 Aug; 15(8):285-90. PubMed ID: 1384197
[TBL] [Abstract][Full Text] [Related]
15. Tumor Targeting and Drug Delivery by Anthrax Toxin.
Bachran C; Leppla SH
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376328
[TBL] [Abstract][Full Text] [Related]
16. Photochemical internalization of tumor-targeted protein toxins.
Weyergang A; Selbo PK; Berstad ME; Bostad M; Berg K
Lasers Surg Med; 2011 Sep; 43(7):721-33. PubMed ID: 22057500
[TBL] [Abstract][Full Text] [Related]
17. A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.
Fuchs H; Bachran C; Li T; Heisler I; Dürkop H; Sutherland M
J Control Release; 2007 Feb; 117(3):342-50. PubMed ID: 17207883
[TBL] [Abstract][Full Text] [Related]
18. Galanin receptor-expressing dorsal horn neurons: role in nociception.
Lemons LL; Wiley RG
Neuropeptides; 2011 Dec; 45(6):377-83. PubMed ID: 21880366
[TBL] [Abstract][Full Text] [Related]
19. The unusual stability of saporin, a candidate for the synthesis of immunotoxins.
Santanché S; Bellelli A; Brunori M
Biochem Biophys Res Commun; 1997 May; 234(1):129-32. PubMed ID: 9168975
[TBL] [Abstract][Full Text] [Related]
20. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
